Hanmi Science Balance Sheet Health
Financial Health criteria checks 4/6
Hanmi Science has a total shareholder equity of ₩933.3B and total debt of ₩214.0B, which brings its debt-to-equity ratio to 22.9%. Its total assets and total liabilities are ₩1,446.3B and ₩513.1B respectively. Hanmi Science's EBIT is ₩52.7B making its interest coverage ratio 6.2. It has cash and short-term investments of ₩95.3B.
Key information
22.93%
Debt to equity ratio
₩214.02b
Debt
| Interest coverage ratio | 6.2x |
| Cash | ₩95.30b |
| Equity | ₩933.25b |
| Total liabilities | ₩513.08b |
| Total assets | ₩1.45t |
Recent financial health updates
Hanmi Science (KRX:008930) Seems To Use Debt Quite Sensibly
Nov 19
Does Hanmi Science (KRX:008930) Have A Healthy Balance Sheet?
Aug 20Hanmi Science (KRX:008930) Has A Pretty Healthy Balance Sheet
May 09Is Hanmi Science (KRX:008930) Using Too Much Debt?
Nov 14Here's Why Hanmi Science (KRX:008930) Can Manage Its Debt Responsibly
Aug 13Is Hanmi Science (KRX:008930) Using Too Much Debt?
Apr 29Recent updates
Risks To Shareholder Returns Are Elevated At These Prices For Hanmi Science Co., Ltd. (KRX:008930)
Feb 08Hanmi Science (KRX:008930) Is Experiencing Growth In Returns On Capital
Jan 23Some Shareholders Feeling Restless Over Hanmi Science Co., Ltd.'s (KRX:008930) P/E Ratio
Dec 12Some Investors May Be Willing To Look Past Hanmi Science's (KRX:008930) Soft Earnings
Nov 24Hanmi Science (KRX:008930) Seems To Use Debt Quite Sensibly
Nov 19Hanmi Science's (KRX:008930) Returns On Capital Are Heading Higher
Oct 13Does Hanmi Science (KRX:008930) Have A Healthy Balance Sheet?
Aug 20What Hanmi Science Co., Ltd.'s (KRX:008930) 29% Share Price Gain Is Not Telling You
Jul 15Returns At Hanmi Science (KRX:008930) Are On The Way Up
Jul 10Hanmi Science Co., Ltd.'s (KRX:008930) 30% Share Price Surge Not Quite Adding Up
May 16Hanmi Science (KRX:008930) Has A Pretty Healthy Balance Sheet
May 09Hanmi Science's (KRX:008930) Conservative Accounting Might Explain Soft Earnings
Mar 25Getting In Cheap On Hanmi Science Co., Ltd. (KRX:008930) Is Unlikely
Feb 11Is Hanmi Science (KRX:008930) Using Too Much Debt?
Nov 14Hanmi Science Co., Ltd. (KRX:008930) Looks Just Right With A 27% Price Jump
Oct 27Returns On Capital Are Showing Encouraging Signs At Hanmi Science (KRX:008930)
Aug 30Here's Why Hanmi Science (KRX:008930) Can Manage Its Debt Responsibly
Aug 13Hanmi Science Co., Ltd. (KRX:008930) Not Flying Under The Radar
Jul 22Is Hanmi Science (KRX:008930) Using Too Much Debt?
Apr 29Hanmi Science Co., Ltd.'s (KRX:008930) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?
Jan 31
We Think Hanmi Science (KRX:008930) Can Stay On Top Of Its Debt
Jan 05Shareholders Are Thrilled That The Hanmi Science (KRX:008930) Share Price Increased 100%
Dec 06Financial Position Analysis
Short Term Liabilities: A008930's short term assets (₩348.6B) do not cover its short term liabilities (₩462.4B).
Long Term Liabilities: A008930's short term assets (₩348.6B) exceed its long term liabilities (₩50.6B).
Debt to Equity History and Analysis
Debt Level: A008930's net debt to equity ratio (12.7%) is considered satisfactory.
Reducing Debt: A008930's debt to equity ratio has increased from 8.4% to 22.9% over the past 5 years.
Debt Coverage: A008930's debt is well covered by operating cash flow (34.2%).
Interest Coverage: A008930's interest payments on its debt are well covered by EBIT (6.2x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/03/08 03:43 |
| End of Day Share Price | 2026/03/06 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Hanmi Science Co., Ltd. is covered by 5 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Young-Ah Han | BofA Global Research |
| Jeehye Song | Goldman Sachs |
| Jung-In Lee | Korea Investment & Securities Co., Ltd. |